Cure8 research brief
This study suggests that genetic risk for Crohn disease and ulcerative colitis may causally increase the risk of developing ankylosing spondylitis, an inflammatory joint condition that commonly co-occurs with IBD.
Patients and clinicians may find this relevant for awareness of joint symptoms and for research into shared biology between gut and joint inflammation.
Researchers studying IBD-AS links, geneticists, clinicians (gastroenterologists and rheumatologists), and patients with IBD concerned about joint symptoms.
This article reports a Mendelian randomization (MR) analysis and meta-analysis testing whether genetic liabilities for inflammatory bowel disease (IBD) — specifically Crohn disease (CD) and ulcerative colitis (UC) — are causally associated with ankylosing spondylitis (AS).
The study used genome-wide association study (GWAS) data from multiple databases and applied several MR methods (inverse-variance weighting, MR-Egger, outlier detection, leave-one-out) to assess robustness.
The main finding presented in the abstract is that genetic liability to CD and UC was positively associated with higher odds of AS in the IVW MR analyses (CD OR ~1.19; UC OR ~1.60) and that a meta-analysis across three independent MR estimates supported these results.
The authors report they tested for instrument strength, heterogeneity, horizontal pleiotropy, and outliers to verify robustness. This is an analysis of genetic association data (MR and meta-analysis) and does not report clinical interventions or patient-level outcomes.
It supports a possible causal link from genetic risk for IBD subtypes to AS risk but does not prove that treating IBD will change AS risk or course.
Mendelian randomization uses genetic variants as proxies for lifelong exposure and can strengthen causal inference but has limitations (pleiotropy, population differences, and reliance on available GWAS).
The abstract-level summary does not provide full methodological or subgroup details; consult the full paper for specifics on GWAS sources, populations, and sensitivity analyses.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The authors have no conflicts of interest to declare.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This review found that children with atopic dermatitis have a modestly higher risk of later developing IBD (both Crohn’s disease and ulcerative colitis). Awareness of this association may help clinicians and families...
The study suggests a possible link between psoriasis, leaky gut, and Crohn’s disease—topics that could help explain why some people with psoriasis report more gut problems. People with psoriasis or IBD may find the...
The work identifies a genetic link (HLA‑DRB1*01:03) to anti‑IL‑10 autoantibodies and describes a small subgroup of IBD patients who may have a distinct immune mechanism driving disease—information that could matter for...
